165 related articles for article (PubMed ID: 851301)
1. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.
Aisner J; Wiernik PH; Schimpff SC
Ann Intern Med; 1977 May; 86(5):539-43. PubMed ID: 851301
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy.
Pennington JE
Arch Intern Med; 1977 Jun; 137(6):769-71. PubMed ID: 869647
[TBL] [Abstract][Full Text] [Related]
3. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.
Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR
Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098
[TBL] [Abstract][Full Text] [Related]
4. [Invasive pulmonary aspergillosis--a diagnostic and therapeutic problem in patients with severe aplastic anemia].
Osterwalder B; Gratwohl A; Nissen C; Hasse J; Grädel E; Dalquen P; Signer E; Speck B
Schweiz Med Wochenschr; 1985 Mar; 115(11):378-80. PubMed ID: 3983589
[TBL] [Abstract][Full Text] [Related]
5. Aspergillosis of the nose and paranasal sinuses in neutropenic patients at an oncology center.
Landoy Z; Rotstein C; Shedd D
Head Neck Surg; 1985; 8(2):83-90. PubMed ID: 3935605
[TBL] [Abstract][Full Text] [Related]
6. Candida and Aspergillus infections in immunocompromised patients: an overview.
Saral R
Rev Infect Dis; 1991; 13(3):487-92. PubMed ID: 1866554
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
Lass-Flörl C; Gunsilius E; Gastl G; Bonatti H; Freund MC; Gschwendtner A; Kropshofer G; Dierich MP; Petzer A
J Clin Microbiol; 2004 Sep; 42(9):4154-7. PubMed ID: 15365004
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
Lionakis MS; Lewis RE; Chamilos G; Kontoyiannis DP
Pharmacotherapy; 2005 Sep; 25(9):1174-80. PubMed ID: 16164392
[TBL] [Abstract][Full Text] [Related]
9. Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia.
Gerson SL; Talbot GH; Hurwitz S; Lusk EJ; Strom BL; Cassileth PA
Am J Med; 1985 Jul; 79(1):57-64. PubMed ID: 4014305
[TBL] [Abstract][Full Text] [Related]
10. [Fever and cavitary infiltrate in a renal transplant recipient].
Rocamora N; Tormo AM; Franco A; Alvarez Avellán L; Olivares J
Nefrologia; 2004; 24 Suppl 3():16-20. PubMed ID: 15219062
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcome of invasive aspergillosis in patients with acute leukemia.
Burch PA; Karp JE; Merz WG; Kuhlman JE; Fishman EK
J Clin Oncol; 1987 Dec; 5(12):1985-93. PubMed ID: 3681380
[TBL] [Abstract][Full Text] [Related]
12. Invasive aspergillosis in children with hematologic malignancies.
Hasan RA; Abuhammour W
Paediatr Drugs; 2006; 8(1):15-24. PubMed ID: 16494509
[TBL] [Abstract][Full Text] [Related]
13. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.
Harari S
Drugs; 1999 Oct; 58(4):621-31. PubMed ID: 10551434
[TBL] [Abstract][Full Text] [Related]
14. Invasive aspergillosis. Progress in early diagnosis and treatment.
Fisher BD; Armstrong D; Yu B; Gold JW
Am J Med; 1981 Oct; 71(4):571-7. PubMed ID: 7282745
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
16. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B.
Weber RS; Lopez-Berestein G
Laryngoscope; 1987 Aug; 97(8 Pt 1):937-41. PubMed ID: 3613794
[TBL] [Abstract][Full Text] [Related]
17. Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective.
Kleinberg M
Med Mycol; 2005 May; 43 Suppl 1():S289-94. PubMed ID: 16110822
[TBL] [Abstract][Full Text] [Related]
18. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
Moosa MY; Alangaden GJ; Manavathu E; Chandrasekar PH
J Antimicrob Chemother; 2002 Jan; 49(1):209-13. PubMed ID: 11751792
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
Petraitis V; Petraitiene R; Solomon J; Kelaher AM; Murray HA; Mya-San C; Bhandary AK; Sein T; Avila NA; Basevicius A; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2006 Apr; 50(4):1510-7. PubMed ID: 16569871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
